Indication
APOL1-Mediated Kidney Disease
The APOL1-Mediated Kidney Disease pipeline: 1 tracked drug.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for APOL1-Mediated Kidney Disease, so this list is not complete.
1 preclinical / unstaged
Market size not yet sourced. How markets are sized ↗